Ross Abrams to Survival Analysis
This is a "connection" page, showing publications Ross Abrams has written about Survival Analysis.
Connection Strength
0.801
-
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):809-16.
Score: 0.089
-
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82.
Score: 0.067
-
Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix.
Score: 0.057
-
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002 May 01; 20(9):2267-76.
Score: 0.049
-
Adjuvant therapy for pancreatic adenocarcinoma. J Gastrointest Surg. 2001 Jan-Feb; 5(1):6-7.
Score: 0.044
-
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704. Oncologist. 2020 03; 25(3):e477-e483.
Score: 0.041
-
Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999 Feb; 22(1):22-8.
Score: 0.039
-
Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center. Cancer J Sci Am. 1998 May-Jun; 4(3):178-84.
Score: 0.037
-
Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1077-85.
Score: 0.036
-
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60.
Score: 0.035
-
Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg Clin North Am. 1995 Oct; 75(5):925-38.
Score: 0.031
-
Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer. 1995 Mar 15; 75(6):1386-90.
Score: 0.030
-
Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993 Feb; 217(2):149-54.
Score: 0.026
-
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
Score: 0.023
-
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1328-35.
Score: 0.022
-
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
Score: 0.021
-
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 05; 299(9):1019-26.
Score: 0.018
-
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
Score: 0.015
-
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2005 Jan; 11(1):39-46.
Score: 0.015
-
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):117-25.
Score: 0.014
-
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6.
Score: 0.014
-
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. J Clin Oncol. 2003 Sep 01; 21(17):3328-34.
Score: 0.013
-
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001 Dec 01; 19(23):4314-21.
Score: 0.012
-
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov-Dec; 4(6):567-79.
Score: 0.011
-
HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci. 1999 Feb 01; 163(1):32-8.
Score: 0.010
-
Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16.
Score: 0.009
-
Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997 May-Jun; 3(3):144-52.
Score: 0.009
-
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65.
Score: 0.008
-
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):143-50.
Score: 0.008